Sanofi Loses Last-Ditch Bid To Upend Eloxatin Deal

Law360, New York (March 2, 2010, 6:47 PM EST) -- A federal judge has deemed enforceable a deal that Sanofi-Aventis U.S. LLC reached with Sun Pharmaceutical Industries Ltd. ending a patent fight over generic versions of Sanofi's colon cancer drug Eloxatin, rejecting Sanofi's second attempt to undo the deal.

U.S. Judge Joel Pisano of the U.S. District Court for the District of New Jersey on Monday denied Sanofi's motion for an order declaring the settlement between the companies unenforceable.

The judge ruled in October that a binding agreement between the companies had in fact been reached,...
To view the full article, register now.